1. Home
  2. CNTX vs GMM Comparison

CNTX vs GMM Comparison

Compare CNTX & GMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNTX
  • GMM
  • Stock Information
  • Founded
  • CNTX 2015
  • GMM 2017
  • Country
  • CNTX United States
  • GMM China
  • Employees
  • CNTX 9
  • GMM N/A
  • Industry
  • CNTX Biotechnology: Pharmaceutical Preparations
  • GMM
  • Sector
  • CNTX Health Care
  • GMM
  • Exchange
  • CNTX Nasdaq
  • GMM Nasdaq
  • Market Cap
  • CNTX 78.0M
  • GMM 70.8M
  • IPO Year
  • CNTX 2021
  • GMM 2023
  • Fundamental
  • Price
  • CNTX $0.78
  • GMM $2.47
  • Analyst Decision
  • CNTX Strong Buy
  • GMM
  • Analyst Count
  • CNTX 6
  • GMM 0
  • Target Price
  • CNTX $6.50
  • GMM N/A
  • AVG Volume (30 Days)
  • CNTX 94.4K
  • GMM 64.3K
  • Earning Date
  • CNTX 05-07-2025
  • GMM 05-20-2025
  • Dividend Yield
  • CNTX N/A
  • GMM N/A
  • EPS Growth
  • CNTX N/A
  • GMM 62.17
  • EPS
  • CNTX N/A
  • GMM 6.37
  • Revenue
  • CNTX N/A
  • GMM $41,360,953.00
  • Revenue This Year
  • CNTX N/A
  • GMM N/A
  • Revenue Next Year
  • CNTX N/A
  • GMM N/A
  • P/E Ratio
  • CNTX N/A
  • GMM $0.37
  • Revenue Growth
  • CNTX N/A
  • GMM 53.82
  • 52 Week Low
  • CNTX $0.55
  • GMM $0.21
  • 52 Week High
  • CNTX $2.75
  • GMM $4.97
  • Technical
  • Relative Strength Index (RSI)
  • CNTX 45.08
  • GMM 46.06
  • Support Level
  • CNTX $0.74
  • GMM $2.13
  • Resistance Level
  • CNTX $0.85
  • GMM $2.64
  • Average True Range (ATR)
  • CNTX 0.09
  • GMM 0.25
  • MACD
  • CNTX -0.02
  • GMM 0.06
  • Stochastic Oscillator
  • CNTX 13.67
  • GMM 73.20

About CNTX Context Therapeutics Inc.

Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.

About GMM Global Mofy Metaverse Limited

Global Mofy AI Ltd operates as a technology solutions provider engaged in virtual content production, digital marketing, and digital assets development for the metaverse industry. It utilizes its proprietary Mofy Lab technology platform which consists of three-dimensional (3D) rebuilt technology and artificial intelligence (AI) interactive technology to create a 3D high-definition virtual version of a wide range of physical world objects such as human, animal, and scenes which can be used in different applications.

Share on Social Networks: